← back to search

Mohammad Hussaini

Moffitt Cancer Center · US
Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Myeloproliferative Neoplasms: Diagnosis and Treatment, and CAR-T cell therapy research.
h-index
20
citations
1,121
works
166
NIH funding
primary concept
Medicine
email

Recent publications

Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk <i>NPM1</i>-mutated AML
Blood Advances 2024cited by 28position: middledoi
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement—A 10-case study and literature review
Human Pathology 2023cited by 4position: middledoi
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
Blood 2022cited by 80position: middledoi
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations
Cancer 2022cited by 22position: middledoi
An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases
Archives of Pathology & Laboratory Medicine 2022cited by 22position: middledoi
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes
Blood Advances 2021cited by 73position: middledoi
Post-transplant relapse of therapy-related MDS as gastric myeloid sarcoma: Case report and review of literature
Leukemia Research Reports 2021cited by 2position: lastdoi
Retrospective Analysis of Minimal Residual Disease Testing By High Throughput Immunosequencing Versus High Sensitivity Flow Cytometry in Multiple Myeloma
Blood 2021cited by 0position: lastdoi
Retrospective Analysis of Minimal Residual Disease Testing By High Throughput Immunosequencing Versus High Sensitivity Flow Cytometry and qPCR in B-Lymphoblastic Leukemia
Blood 2021cited by 0position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey E. Lancet · Moffitt Cancer Center4 papers (2021–2024)Kendra Sweet · Moffitt Cancer Center3 papers (2021–2024)Onyee Chan · University of Arizona3 papers (2021–2024)Chetasi Talati · AbbVie (United States)3 papers (2021–2024)Ling Zhang · Moffitt Cancer Center3 papers (2022–2024)Rami S. Komrokji · Moffitt Cancer Center3 papers (2021–2024)Seongseok Yun · University of Arizona3 papers (2021–2024)Jinming Song · University of South Florida3 papers (2021–2024)David A. Sallman · Moffitt Cancer Center3 papers (2021–2024)Eric Padron · Moffitt Cancer Center3 papers (2021–2024)Andrew Kuykendall · Moffitt Cancer Center2 papers (2022–2024)Nagehan Pakasticali · Southwestern Medical Center2 papers (2021–2021)Yehuda E. Deutsch · Moffitt Cancer Center2 papers (2022–2024)Anwar Ulla Khan · Florida State University2 papers (2021–2021)Omar Fathalla · University of South Florida2 papers (2021–2021)Bijal Shah · Stanford University2 papers (2021–2023)Somedeb Ball · University of South Florida2 papers (2022–2024) · 1 papers (2023–2023)Caroline A. Coughlin · University of Miami1 papers (2022–2022)Chuanyi M. Lu · San Francisco VA Medical Center1 papers (2023–2023)